Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 2Recruiting 2Completed 2Active not recruiting 2Unknown 1Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 1

Interventions

Bevacizumab 4Specimen Handling 3Magnetic Resonance Spectroscopy 2Everolimus 2Biopsy 2trametinib 1relatlimab 1pembrolizumab 1lutetium Lu 177 dotatate 1fluoromisonidazole 1fludarabine phosphate 1antineoplaston AS 2-1 1antineoplaston A10 1aldesleukin 1X-Rays 1Transcranial Magnetic Stimulation 1TPI-287 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Sunitinib 1Radiotherapy, Intensity-Modulated 1Radiosurgery 1Nivolumab 1Niacinamide 1Niacin 1Metformin 1Mental Status and Dementia Tests 1Magnetic Resonance Imaging 1Lomustine 1Lasers, Solid-State 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Diet, Ketogenic × CNS × Clear all
NCT05183204 2025-12-18

Paxalisib With a High Fat, Low Carb Diet and Metformin for Glioblastoma

Weill Medical College of Cornell University

Phase 2 Suspended
33 enrolled
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡